Incidence of acute kidney injury in patients with relapsed and refractory multiple myeloma treated with teclistamab vs chimeric antigen receptor T-cell therapy

被引：0
|
作者：
Charkviani, Mariam
Vaughan, Lisa E.
Sandahl, Tyler B.
Lin, Yi
Leung, Nelson
Herrmann, Sandra M.
机构：
[1] Mayo Clin, Div Nephrol & Hypertens, Rochester, MN USA
[2] Mayo Clin, Rochester, MN USA
[3] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN USA
[4] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7542
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Incidence and Risk Factors Associated With Bleeding Following Anti-B-Cell Maturation Antigen (BCMA) Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma (RRMM)
    Mohammed, Turab
    Peres, Lauren
    Colinleitzinger, Christelle
    Puglianini, Omar Castaneda
    Oswald, Laura
    De Avila, Gabe
    Grajales-Cruz, Ariel
    Blue, Brandon
    Ochoa-Bayona, Jose
    Khimani, Farhad
    Faramand, Rawan
    Elmariah, Hany
    Lazaryan, Aleksandr
    Jain, Michael
    Liu, Hein
    Nishihori, Taiga
    Shain, Ken
    Baz, Rachid
    Alsina, Melissa
    Locke, Frederick
    Freeman, Ciara
    Hansen, Doris
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S473 - S474
  • [32] Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Ma, Sha
    Li, Hujun
    Zhou, Dian
    Zhang, Xiaotian
    Shi, Ming
    Cao, Jiang
    Qi, Yuekun
    Xia, Jieyun
    Liu, Yang
    Wang, Xue
    Li, Depeng
    Sang, Wei
    Yan, Zhiling
    Zhu, Feng
    Sun, Haiying
    Cheng, Hai
    Zheng, Junnian
    Xu, Kailin
    Li, Zhenyu
    Qi, Kunmin
    Wang, Ying
    CYTOTHERAPY, 2023, 25 (06) : 653 - 658
  • [33] Real-world applicability of commercial chimeric antigen receptor T-cell therapy among older adults with relapsed and/or refractory multiple myeloma
    Giri, Smith
    Bal, Susan
    Godby, Kelly N.
    Ravi, Gayathri
    Clark, Deanna
    Ubersax, Clare
    Cooley, Abigail
    White, Priscila
    Rangarajan, Sunil
    Williams, Grant R.
    Costa, Luciano J.
    AMERICAN JOURNAL OF HEMATOLOGY, 2022, 97 (04) : E153 - E155
  • [34] An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis
    Pereira, Rita
    Bergantim, Rui
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
  • [35] Chimeric antigen receptor T-cell therapies for multiple myeloma
    Mikkilineni, Lekha
    Kochenderfer, James N.
    BLOOD, 2017, 130 (24) : 2594 - 2602
  • [36] Chimeric antigen receptor T cell therapy for multiple myeloma
    Kana Hasegawa
    Naoki Hosen
    Inflammation and Regeneration, 39
  • [37] CAR T-cell therapy for relapsed or refractory multiple myeloma
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (06): : E297 - E297
  • [38] Chimeric antigen receptor T cell therapy for multiple myeloma
    Hasegawa, Kana
    Hosen, Naoki
    INFLAMMATION AND REGENERATION, 2019, 39 (1)
  • [39] Prophylactic Tocilizumab in Patients with Relapsed Refractory Lymphoma Treated with Anti CD19 Chimeric Antigen Receptor T-Cell Therapy
    Ahmed, Nausheen
    Caimi, Paolo
    Reese, Jane S.
    Otegbeye, Folashade
    Patel, Seema
    Schneider, Dina
    Boughan, Kirsten M.
    Cooper, Brenda
    Gallogly, Molly
    Kruger, Winfred
    Worden, Andrew
    Kadan, Michael
    Lopes, Filipa Blasco Tavares Pereira
    Sharma, Ashish
    Malek, Ehsan
    Metheny, Leland
    Tomlinson, Benjamin
    Wald, David
    Sekaly, Rafick-Pierre
    Orentas, Rimas
    Dropulic, Boro
    de Lima, Marcos
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S275 - S276
  • [40] EFFICACY AND TOXICITY FOR CD7 CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY IN PATIENTS WITH RELAPSED/ REFRACTORY T-CELL LYMPHOMA
    Su, Guoai
    Yang, Fan
    Shi, Hui
    Liu, Rui
    Li, Ruiting
    Xu, Teng
    Feng, Shaoma
    Zheng, Peihao
    Guo, Yuelu
    Ma, Lixia
    Deng, Biping
    Ke, Xiaoyan
    Hu, Kai
    BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 196 - 197
12345